Search Results - chih-tsung+lin

2 Results

Sort By:

Treatments for tuberculosis and non-tuberculous mycobacterial infections: dual-targeted rifamycin-AAP conjugates (RifaAAPs)

collapse; } Invention Summary: RifaAAPs are novel dual-targeted, low-resistance-emergence, orally-available compounds for treatment of tuberculosis (TB) and non-tuberculous mycobacterial (NTM) infections--including drug-resistant, multi-drug-resistant (MDR), and extensively-drug-resistant (XDR) strains. Researchers indicate that...

Published: 1/31/2025 | Inventor(s): Richard Ebright, Yon Ebright, Chih-Tsung Lin

Keywords(s): Antibacterial

Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Therapeutics

ANTIBACTERIAL AGENTS: DUAL-TARGETED RNA POLYMERASE INHIBITORS (BENZOXAZINO-RIFAAAPS

Invention Summary: RifaAAPs are novel dual-targeted, low-resistance-emergence, orally-available compounds for treatment of tuberculosis (TB) and non-tuberculous mycobacterial (NTM) infections--including drug-resistant, multi-drug-resistant (MDR), and extensively-drug-resistant (XDR) strains. Researchers indicate that RifaAAPs comprise...

Published: 1/31/2025 | Inventor(s): Richard Ebright, Yon Ebright, Chih-Tsung Lin

Keywords(s): Antibacterial

Category(s): Technology Classifications > Infectious Disease, Technology Classifications > Healthcare & Life Sciences